Newsroom.regeneron.com

Regeneron Announces New U.S. Government Agreement to …

WebTARRYTOWN, N.Y., Sept. 14, 2021 /PRNewswire/ -- New agreement for 1.4 million doses of REGEN-COV, brings total purchased by the U.S. government to nearly 3 million …

Actived: 2 days ago

URL: https://newsroom.regeneron.com/news-releases/news-release-details/regeneron-announces-new-us-government-agreement-purchase

INVESTORS & MEDIA

WebTARRYTOWN, N.Y., Oct. 14, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) …

Category:  Food Go Health

New England Journal of Medicine Publishes Positive Phase 3 Trial

WebTARRYTOWN, N.Y., Aug. 4, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicine (NEJM) …

Category:  Medicine Go Health

INVESTORS & MEDIA

WebTARRYTOWN, N.Y., Sept. 29, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicine (NEJM) …

Category:  Medicine Go Health

Regeneron’s Casirivimab and Imdevimab Antibody Cocktail for …

WebTARRYTOWN, N.Y. , Nov. 21, 2020 /PRNewswire/ -- First treatment of any kind to have prospectively confirmed and statistically significant anti-viral activity against SARS-CoV-2 …

Category:  Health Go Health

INVESTORS & MEDIA

WebSupply and Distribution Update REGEN-COV is available throughout the U.S. without restriction – information on availability in your area is available from the …

Category:  Health Go Health

INVESTORS & MEDIA

WebTARRYTOWN, N.Y. , Nov. 8, 2021 /PRNewswire/ -- Single dose of REGEN-COV (1,200 mg subcutaneous) reduced the risk of COVID-19 by 81.6% during the pre-specified follow-up …

Category:  Health Go Health

U.S. Food and Drug Administration Revises Emergency Use …

Web1 . January 24, 2022 . U.S. Food and Drug Administration Revises Emergency Use Authorization for REGEN-COV® (casirivimab and imdevimab) Antibody Cocktail due to …

Category:  Food Go Health

INVESTORS & MEDIA

WebTARRYTOWN, N.Y. , Jan. 26, 2021 /PRNewswire/ -- Reduction in overall infections seen within first week, with 100% prevention of symptomatic infections Markedly decreased …

Category:  Health Go Health

FDA Approves First-in-class Evkeeza™ (evinacumab-dgnb) for …

WebTARRYTOWN, N.Y., Feb. 11, 2021 /PRNewswire/ -- Homozygous familial hypercholesterolemia (HoFH) is an ultra-rare inherited condition that affects …

Category:  Health Go Health

Regeneron Genetics Center and Geisinger Study Finds Life …

WebTARRYTOWN, N.Y., Dec. 22, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Geisinger Health System (Geisinger) today announced that …

Category:  Health Go Health

INVESTORS & MEDIA

WebThree times more patients treated with Kevzara achieved sustained remission compared to placebo in Phase 3 trial Kevzara now approved to treat two chronic inflammatory …

Category:  Health Go Health

Regeneron Genetics Center® Publication in New England Journal …

WebTARRYTOWN, N.Y., March 21, 2018 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a publication in the New England Journal of …

Category:  Health Go Health

Safety and Preliminary Clinical Activity of REGN5458, an Anti …

WebIntroduction • Multiple myeloma (MM) is characterized by the expansion of malignant plasma cells which express the cell surface protein B-cell maturation antigen (BCMA).

Category:  Health Go Health

Regeneron and Sanofi to Lower Net Price of Praluent® …

WebTARRYTOWN, N.Y. and BRIDGEWATER, N.J. and ST. LOUIS, May 1, 2018 /PRNewswire/ -- Agreement provides Praluent at lower net price and enables …

Category:  Health Go Health

INVESTORS & MEDIA

WebSonoma Biotherapeutics to receive $75 million upfront, inclusive of $45 million cash and $30 million equity investment; potential for an additional $45 million development milestone …

Category:  Health Go Health

Regeneron Genetics Center® Publication in New England …

WebRegeneron Genetics Center® Publication in New England Journal of Medicine Identifies New Genetic Variant Providing Protection from Chronic Liver Disease

Category:  Medicine Go Health

INVESTORS & MEDIA

WebRegeneron Contacts: Media Relations Sharon Chen Tel: +1 914-847-1546 [email protected]: Investor Relations Vesna Tosic Tel: +1 914-847-5443 …

Category:  Health Go Health

Regeneron Announces Appointment of Marion McCourt as Senior …

WebTARRYTOWN, N.Y., Feb. 12, 2018 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced the appointment of Marion McCourt as the Senior …

Category:  Health Go Health

INVESTORS & MEDIA

WebTARRYTOWN, N.Y. and AURORA, Colo. , May 11, 2020 /PRNewswire/ -- Regeneron Genetics Center will sequence 450,000 informed and consented patients …

Category:  Health Go Health

INVESTORS & MEDIA

WebHoFH is an ultra-rare inherited condition, and the most severe form of familial hypercholesterolemia (FH). The disease affects 1 in 160,000 to 300,000 people …

Category:  Health Go Health

2022 Responsibility Report

WebIn 2022, we made reporting potential hazards and near misses even easier — colleagues at our research and preclinical development sites can submit a report right from their phone …

Category:  Health Go Health